Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial.

Research output: Contribution to journalArticle

Abstract

In rheumatoid arthritis (RA), predictive biomarkers for subsequent radiographic progression (RP) could improve therapeutic choices for individual patients. We previously showed that the multibiomarker disease activity (MBDA) score in patients with newly diagnosed RA identified patients at risk for RP. We evaluated the MBDA score at multiple time-points as a predictor of RP during 2 years of follow-up.

Details

Authors
  • Karen Hambardzumyan
  • Rebecca J Bolce
  • Saedis Saevarsdottir
  • Kristina Forslind
  • JOHAN KARLSSON WALLMAN
  • Scott E Cruickshank
  • Eric H Sasso
  • David Chernoff
  • Ronald F van Vollenhoven
Organisations
External organisations
  • Helsingborg Hospital
  • Karolinska University Hospital
  • Crescendo Bioscience Inc.
  • Karolinska Institutet
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Rheumatology and Autoimmunity
Original languageEnglish
Pages (from-to)e000197
JournalRMD Open
Volume2
Issue number1
Publication statusPublished - 2016
Publication categoryResearch
Peer-reviewedYes